BTK inhibitors: can these drugs tackle cancer and autoimmunity?
Bruton tyrosine kinase (BTK) inhibitors are a class of drugs that were initially developed to control the spread of cancer. It was first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune …